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Abstract
Background: Despite the fact that the alimentary tract is part of the body's first line of defense
against orally ingested xenobiotica, little is known about the distribution and expression of
cytochrome P450 (CYP) enzymes in human colon. Therefore, expression and protein levels of four
representative CYPs (CYP2C(8), CYP2E1, CYP3A4, and CYP3A5) were determined in human
colon mucosa biopsies obtained from ascending, descending and sigmoid colon.
Methods: Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 mRNA in colon mucosa was
determined by RT-PCR. Protein concentration of CYPs was determined using Western blot
methods.
Results: Extensive interindividual variability was found for the expression of most of the genes.
However, expression of CYP2C mRNA levels were significantly higher in the ascending colon than
in the sigmoid colon. In contrast, mRNA levels of CYP2E1 and CYP3A5 were significantly lower in
the ascending colon in comparison to the descending and sigmoid colon. In sigmoid colon protein
levels of CYP2C8 were significantly higher by ~73% than in the descending colon. In contrast,
protein concentration of CYP2E1 was significantly lower by ~81% in the sigmoid colon in
comparison to the descending colon.
Conclusion: The current data suggest that the expression of CYP2C, CYP2E1, and CYP3A5 varies
in different parts of the colon.
Background
Throughout the last decades drug metabolism in the ali-
mentary tract has received growing attention as part of the
body's first line of defense against orally ingested harmful
xenobiotica. Most xenobiotic compounds require an
enzymatic activation to form a carcinogen or toxicant. The
reactive intermediates resulting form enzymatic drug
metabolism are often unstable and therefore are unlikely
to be transported from the liver to other tissues to exert
toxicity. Therefore, the chemical toxicity found in extrahe-
patic tissue often results from cellular metabolic activities
in the organ. However, knowledge on the variability and
regulation of expression of drug metabolizing enzymes in
the human gastrointestinal tract and particularly the large
intestine is poor in comparison with the "classical" drug
metabolizing organs (e.g. liver).
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Cytochrome P450 (CYP) is a multi-gene superfamily of
heme-containing enzymes catalyzing the oxidative metab-
olism of many compounds [1]. CYP families 1, 2, and 3,
which are the main CYP families participating in the
metabolism of xenobiotics, are highly expressed within
the liver, but are also expressed in extrahepatic tissues (for
review see [2]). Members of the CYP families 2 and 3, and
herein especially CYP2C and CYP3A4, are present in rela-
tive high concentrations in small intestinal epithelium [3-
5], and it has been suggested that they facilitate a barrier
function to protects the small intestine from toxic xenobi-
otics [4]. Furthermore, it has been shown that total CYP
content increases slightly in the progression from duode-
num to jejunum and subsequently decreases significantly
in the ileum [3]. Despite the fact that it has been suggested
that the absence of some of these microsomal enzymes in
the colon may be involved in the comparably high inci-
dence of carcinoma in this organ [4], information availa-
ble on the expression of CYPs in the large intestine of
humans is limited and some of the available data are con-
tradictory. Therefore, the main purpose of the present
study was to evaluate the expression pattern, protein con-
centration, and distribution of four representative CYPs
(CYP2C, CYP2E1, CYP3A4, and CYP3A5) in ascending,
descending and sigmoid human colon mucosa of virtually
healthy subjects. Furthermore, protein levels were related
to mRNA expression pattern.
Material and methods
Subjects
The study was approved by the Ethics Committee of the
Medical Association Stuttgart, Germany. Informed con-
sent was obtained from all subjects included in the study.
During routinely performed coloscopies, two biopsy spec-
imens (each 5–10 mg) of normal colon mucosa were
obtained from either ascending (n = 10), descending (n =
7), or sigmoid (n = 24) colon of a total of 41 volunteers
(age 30 – 80). None of the subjects displayed any macro-
scopic evidence of colonic neoplasia or other disease in
colon. All patients completed a questionnaire concerning
factors that may influence the expression of cytochrome
P450 such as medication, smoking, and alcohol con-
sumption (see Table 1). Neither anthropometrics nor life-
style and drug intake differed significantly between
donors of biopsy specimens of ascending, descending,
and sigmoid colon. Furthermore, no significant correla-
tion was observed between these parameters and the pro-
tein levels as well as mRNA expression patterns of CYPs
investigated. Subjects and controls did not consume drugs
known to interfere with or to induce CYPs investigated in
this study.
Tissues and isolation of total RNA and protein
All colon mucosa specimens were immediately frozen in
liquid nitrogen after excision and stored at -80°C. Both
total RNA and protein was isolated using Trizol reagent
(Invitrogene, Gaithersburg, MD, USA).
Electrophoresis and immunoblotting
Protein concentration was determined using a commer-
cially available Bradford assay (BioRad, Munich, Ger-
many). Twenty to 30 µg of total protein were separated by
electrophoresis through a 9% SDS-polyacrylamid gel and
was transferred onto a nitrocellulose membrane. To
ensure equal loading of samples, membranes were stained
with Ponceau red. In addition, some blots were probed for
β-actin (Sigma, Munich, Germany) to ascertain identical
protein loading of samples. Membranes were blocked in
5% non-fat milk in Tris-buffered saline-Tween 20 (TBST,
0.01% v/v Tween 20) and probed with dilutions of pri-
mary antibodies in TBS followed by an incubation with
the secondary antibody. Anti-CYP2E1 and anti-CYP3A4
antibodies were generous gifts of Dr. M. Ingelman-Sund-
berg, Karolinska Institute, Stockholm, Sweden; anti-
CYP2C8 and anti-CYP3A5 were purchased from Chemi-
con, Inc. (Frankfurt, Germany). The protein/antibody
complex was visualized by enhanced chemiluminescence
(SuperSignal® West Dura, Pierce, Bad Godesberg, Ger-
many). Blots were photographed (Camera LAS 1000, Fuji,
USA) and densitometric analysis was performed using the
software AIDA (Raytest, Isotopenmessgeraete, Strauben-
hardt, Germany). As positive control and for semiquanti-
fication, serial dilutions of microsomes and Supersomes
derived from cell lines and clones expressing human
CYP2C8, CYP2E1, CYP3A4, and CYP3A5 (Gentest Corpo-
ration, Woburn, MA, USA) respectively were loaded on
each gel.
Reverse transcription and PCR
The integrity and concentration of RNA was analyzed in a
1.2% agarose gel. First-strand complementary DNA was
synthesized from 200 ng of total RNA using a First-Strand
cDNA Synthesis Kit (Invitrogen, Gaithersburg, MD, USA).
Sequences of primers are summarized Table 2. The PCR







n 10 7 24
Age 52 ± 9 54 ± 15 55 ± 9
Sex : Female/male 5/5 1/6 8/16
BMI 26.5 ± 5.7 27.8 ± 4.9 25.4 ± 4.0
Cigarette use
Yes/No 3/7 3/4 4/20
(number/d) 2.8 ± 6.2 8.3 ± 9.8 1.5 ± 4.6
Alcohol consumption
Yes/No 3/7 2/5 12/12
(g/d) 9.4 ± 14.6 8.2 ± 7.8 9.8 ± 12.6
All data are expressed as means ± SD. (BMI = body mass index)BMC Clinical Pharmacology 2005, 5:4 http://www.biomedcentral.com/1472-6904/5/4
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reaction consisted of 0.6 µl of cDNA, 10 × PCR buffer, 200
µM dNTPs (Boehringer, Mannheim, Germany), BSA (0.25
mg/ml), DMSO (2% v/v), 0.5 µM of specific primer and
0.5 U Taq-polymerase (Promega, Madison, WI, USA), and
water to a final volume of 10 µl. For amplifications of the
four cytochrome P450 cDNAs, PCR-conditions were as
follows: 3 s at 94°C, 3 s at 45°C, 30 s at 72°C, for 32
cycles. Amplification of histone 3.3 was performed apply-
ing the following conditions: 3 s at 94°C, 3 s at 45°C, and
30 s at 72°C for 30 cycles. All PCR amplifications were
carried out in triplicate in a Rapid Cycler (Idaho Tec.,
USA) within the linear range of the reaction. PCR prod-
ucts were separated in a 1.5% agarose gel, stained with
ethidium bromide and photographed using a digital cam-
era from Biometra (Goettingen, Germany). To ensure the
success of PCR, human liver cDNA was used as a positive
control.
Statistical analysis
Mann-Whitney U test, Chi-square-test for crosstabulation
tables, and analysis of variances (ANOVA) with the Post-
hoc test of Tukey was used for the determination of statis-
tical significance as appropriate. A P value of less than
0.05 was selected as the level of significance before the
study.
Results
Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 
mRNA in ascending, descending, and sigmoid colon
The presence of a band of the correct size in agarose gels
was regarded as evidence of gene expression. Expression
of the housekeeping gene histone 3.3 was detected in all
samples. A total of 10 specimens obtained from the
ascending colon, 6 specimens from the descending colon
and 21 specimens obtained form the sigmoid colon were
included in the analysis of mRNA expression. Three RNA
samples obtained form the sigmoid colon had to be
excluded as RNA concentrations were too low. Represent-
ative gels depicting RNA integrity and results of RT-PCR
measurements are shown in Figure 1.
Expression of CYP2C was found to be higher in the
ascending colon than in the descending and sigmoid
colon. However, due to large interindividual variability
differences in CYP2C expression were only significant
between the ascending and the sigmoid colon. In the
ascending colon expression of CYP2E1 was not detecta-
ble. In the descending and the sigmoid colon expression
of CYP2E1 did not differ significantly, however expression
of CYP2E1 was detectable. Expression of CYP3A4 did not
differ between the three regions of colon investigated. In
contrast, CYP3A5 mRNA expression was significantly
higher in the descending and the sigmoid colon in com-
parison to the ascending colon. Specifically, in the
descending colon CYP3A5 mRNA expression was ~2-fold
and in the sigmoid colon ~3-fold higher than in the
ascending colon. No differences in CYP3A5 expression
were found between the descending and sigmoid colon.
Protein levels of CYP2C8, CYP2E1, CYP3A4, and CP3A5 in 
the descending and sigmoid colon
Due to a low protein content of some mucosal biopsies,
Western blot analyses of CYP2E1, CYP3A4, and CYP3A5
were only performed in 6 tissue specimens obtained from
the descending and 24 from sigmoid colon. Since higher
protein concentrations were needed for the detection of
CYP2C8, protein concentration of CYP2C8 was only
determined in 17 specimens taken from sigmoid colon.
Biopsies obtained from the ascending region of the colon
were not included in the analysis as sufficient protein con-
centrations for Western blot analysis were only obtained
from four samples. Figure 2 depicts representative West-
ern blot and quantitative analysis of protein.
The mean protein level of CYP2C8 was significantly lower
in the descending colon when compared with the sigmoid
colon. Specifically, protein levels of CYP2C8 were found
to be ~73% lower in the descending colon in comparison
to the sigmoid colon. In contrast, protein concentration of
CYP2E1 was significantly higher by ~81% in the descend-
ing colon compared to the sigmoid colon. However, no
significant differences were found when comparing pro-
tein levels of CYP3A4 and CYP3A5 between the descend-
ing and sigmoid colon.
Relation of protein levels and mRNA expression pattern of 
CYPs in sigmoid colon
To address the question whether mRNA profiles corre-
lated CYP protein concentration in colonic mucosa, pro-
tein levels of CYPs of subjects with detectable mRNA
Table 2: Primers used for RT-PCR analysis
Sense primer location Antisense primer location PCR product (bp) Reference
Histone 3.3 GCGTGCTAGCTGGATGTCTT CCACTGAACTTCTGATTCGC 150 [18]
CYP2C8-19 GCTAAAGTCCAGGAAGAGATTGA TCCTGCTGAGAAAGGCATGAAGT 332 [19]
CYP2E1 AGCACAACTCTGAGATATGG ATAGTCACTGTACTTGAACT 365 [19]
CYP3A4 CCAAGCTATGCTCTTCACCG TCAGGCTCCACTTACGGTGC 324 [20]
CYP3A5 TGTCCAGCAGAAACTGCAAA TTGAAGAAGTCCTTGCGTGTC 472 [20]BMC Clinical Pharmacology 2005, 5:4 http://www.biomedcentral.com/1472-6904/5/4
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CYP3A5, CYP2E1, CYP3A4, and CYP2C mRNA expression in human colon mucosa obtained ascending, descending, and sig- moid colon Figure 1
CYP3A5, CYP2E1, CYP3A4, and CYP2C mRNA expression in human colon mucosa obtained ascending, 
descending, and sigmoid colon. (A) Representative agarose gel of mRNA integrity. Lane 1 and 10 = positive control, lane 
2–9 = RNA extracted from colonic mucosa biopsies. (B) Representative photomicrograph of RT-PCR products of three sub-
jects. All measurements were carried out in triplicate. Lane 1 = Histone 3.3; Lane 2 = CYP3A5; Lane 3 = CYP2E1; Lane 4 = 
CYP3A4; Lane 5 = CYP2C, bp = base pairs, A = ascending colon, D = descending colon, S = sigmoid colon. (C) Quantitative 
analysis of mRNA expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 in human ascending, descending, and sigmoid colon. 
Data are normalized to histone 3.3 expression. Data are means ± SEM. (n.d. = not detectable, aP < 0.05 compared to ascending 
colon)BMC Clinical Pharmacology 2005, 5:4 http://www.biomedcentral.com/1472-6904/5/4
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CYP2E1, CYP2C8, CYP3A4, CYP3A5 protein levels in normal human colon mucosa obtained from descending and sigmoid  colon Figure 2
CYP2E1, CYP2C8, CYP3A4, CYP3A5 protein levels in normal human colon mucosa obtained from descending 
and sigmoid colon. (A) Representative Western blot of CYP2E1, CYP2C8, CYP3A4, CYP3A5. (B) Representative Western 
blot of β-actin performed in 5 different individuals. (C) Quantitative analysis of blots. Data are means ± SEM. (aP < 0.05 com-
pared to descending colon)BMC Clinical Pharmacology 2005, 5:4 http://www.biomedcentral.com/1472-6904/5/4
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expression were compared with those with undetectable
mRNA expression of the respective CYP. Since the sample
number of biopsies obtained from the ascending and
descending colon was too small to perform a statistical
analysis (ascending: n = 4; descending: n = 6), this com-
parison was only performed for the sigmoid colon.
Results are summarized in Figure 3. Interestingly, no sig-
nificant differences were found when comparing protein
levels of CYP2C8, CYP2E1, CYP3A4, and CYP3A5 of sub-
jects with detectable mRNA expression of these CYPs with
those with undetectable mRNA levels. No correlation was
found between CYP2E1 expression and individual alco-
hol consumption.
Discussion
Abundance of CYPs differs between ascending, descending, 
and sigmoid colon and between individuals
It has been suggested that the expression of CYPs (e.g. the
absence of expression of certain CYPs) in the colon might
be an important factor in the susceptibility of this organ
for cancer. Expression of members of the CYP2C-, CYP2E-
, and CYP3A-family in normal mucosa along with sub-
stantial interindividual differences in the expression levels
of CYPs in the colon has been reported by others [6-11].
However, some of the available data are contradictory and
most studies either determined mRNA or protein levels.
Furthermore, detailed information on the distribution of
CYPs within the colon (e.g. distal vs. proximal colon) is
lacking. For example, McKay et al. [6] detected CYP3A
protein in two out of 13 morphologically normal colon
mucosa specimens of patients with neoplasia in the
colon. Similar results were also reported by Mercurio et
al.[7] and McKinnon et al.[8] for CYP3A4 and CYP3A5
mRNA expression in colon. Using immunohistochemical
methods, Yokose et al. [9] reported the presence of
CYP2C(8–19) in healthy human colon mucosa also find-
ing large interindividual differences. In contrast, Western
blot analyses by de Waziers et al. [10] and Massaad et al.
[11] applying conventional immunoperoxidase staining
procedure failed to detect the expression of cytochromes
P450 2C8-10 and 2E1 protein in human colon mucosa. In
the present study, the expression and protein levels of four
representative CYPs were determined in different regions
of the large intestine. At the levels of mRNA expression
CYP2C, CYP2E1, and CYP3A5 concentration was found
to be significantly different between the three different
regions investigated with CYP2C mRNA expression being
significantly higher in proximal regions of the colon than
in the distal (e.g. descending and sigmoid colon). In con-
trast, mRNA expression of CYP2E1 and CYP3A5 was sig-
nificantly lower in the proximal colon (i.e. ascending)
than in the distal part of the organ. However, in accord-
ance with the findings of others, mRNA expression of all
four CYPs was found to vary extensively between individ-
uals, even though expression of histone 3.3, which was
used as housekeeping gene, was detected in all samples. At
the level of protein, CYP2C8 concentration was found to
be lower in the descending colon when compared with
the more distal sigmoid region of the colon. Contrary,
CYP2E1 protein levels were higher in descending colon
than in the sigmoid colon. Taken together, these data sug-
gest that CYP expression in colon not only varies among
individuals but also among different regions of the organ.
CYP protein levels and mRNA expression are not related
Studies of the mRNA and protein expression of CYP3A4
and CYP3A5 in rat duodenum and kidney, as well as the
expression of CYP2C7 (corresponding to human
CYP2C8) and CYP2E1 in rat colon mucosa, revealed a dis-
sociation of mRNA expression and protein levels of CYPs.
[12] Hakkak et al. [13] suggested that the expression of
CYPs is not solely regulated at the transcriptional level.
This is supported by results of in vitro investigations in rat
hepatocytes, which indicated that protein level of CYP2E1
is regulated by posttranscriptional ligand-dependent sta-
bilization of the enzyme [14]. Similar mechanisms have
been described for rat and human CYP3A [4,15,16]. Fur-
Relation of CYP2E1, CYP2C8, CYP3A4, CYP3A5 protein  levels and mRNA expression pattern in normal human colon  mucosa obtained from sigmoid colon Figure 3
Relation of CYP2E1, CYP2C8, CYP3A4, CYP3A5 
protein levels and mRNA expression pattern in nor-
mal human colon mucosa obtained from sigmoid 
colon. Comparison of protein levels of CYP2E1, CYP2C8, 
CYP3A4, and CYP3A5 of subjects with detectable mRNA 
expression and subjects with no detectable mRNA expres-
sion of the respective CYP. Data are means ± SEM.BMC Clinical Pharmacology 2005, 5:4 http://www.biomedcentral.com/1472-6904/5/4
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thermore, in vitro studies using cultured hepatocytes
showed that only ~60–70% of mRNA encoding for
CYP2E1 is translated [17]. Indeed, in the present study, no
differences with respect to protein levels of subjects with
detectable and undetectable mRNA expression of the
CYPs were found.
Conclusion
In summary, interindividual variability seems to be a
characteristic of CYP expression in colon as has been
reported by others before [6-11]. However, in the present
study we found significant differences of CYP2C(8),
CYP2E1 and CYP3A5 mRNA expression and protein lev-
els between different regions of the colon (e.g. ascending,
descending, and sigmoid colon). Metabolic implications
of this "zonification" remain to be determined. Neverthe-
less, differences found in the present study might result in
alterations of detoxification of carcinogens or pro-carcin-
ogens and therefore contribute to high susceptibility of
this organ to carcinoma.
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